Alpha Synuclein Products
| Product Description | Catalog No. | Monomer Source |
|---|---|---|
| Human Alpha Synuclein Pre-formed Fibrils (Type 1) | SPR-322 | Human Alpha Synuclein Monomers (SPR-321) |
| Human Alpha Synuclein Pre-formed Fibrils (ATTO 594 conjugated, Type 1) | SPR-322-A594 | Human Alpha Synuclein Monomers (SPR-321) |
| Mouse Alpha Synuclein Pre-formed Fibrils (Type 1) | SPR-324 | Mouse Alpha Synuclein Monomers (SPR-323) |
| Human Alpha Synuclein Pre-formed Fibrils (Type 2) | SPR-317 | Human Alpha Synuclein Monomers (Type 2) (SPR-316) |
| Human Alpha Synuclein N-Terminal Acetylated Pre-formed Fibrils (Type 1) | SPR-332 | Human N-Terminal Acetylated Alpha Synuclein Monomers (SPR-331) |
| Human Alpha Synuclein A53T Mutant Pre-formed Fibrils (Type 1) | SPR-326 | Human Alpha Synuclein A53T Mutant Monomers (Type 1) (SPR-325) |
| Human Alpha Synuclein S87N Mutant Pre-formed Fibrils | SPR-500 | Human Alpha Synuclein S87N Mutant Monomers (Type 1) (SPR-499) |
| Human Alpha Synuclein S129A Mutant Pre-formed Fibrils | SPR-506 | Human Alpha Synuclein S129A Mutant Monomers (SPR-505) |
| Human Alpha Synuclein TNG (A53T, S87N, N103G) Mutant Pre-formed Fibrils | SPR-504 | Human Alpha Synuclein TNG (A53T, S87N, N103G) Mutant Monomers (SPR-503) |
| Rat Alpha Synuclein Pre-formed Fibrils | SPR-482 | Rat Alpha Synuclein Monomers (SPR-481) |
| Human Alpha Synuclein Filaments (Immature Fibrils) | SPR-450 | Human Alpha Synuclein Monomers (SPR-321) |
| Monomers | |
|---|---|
| Catalog | Description |
| SPR-316 | Human Alpha Synuclein Monomers (Type 2) |
| SPR-321 | Human Alpha Synuclein Monomers (Type 1) |
| SPR-323 | Mouse Alpha Synuclein Monomers (Type 1) |
| SPR-325 | Human Alpha Synuclein A53T Mutant Monomers (Type 1) |
| SPR-331 | Human Alpha Synuclein N-Terminal Acetylated Monomers (Type 1) |
| SPR-481 | Rat Alpha Synuclein Monomers |
| Catalog | Target | Clone | Host | Applications | Reactivity |
|---|---|---|---|---|---|
| SMC-530 | Alpha Synuclein | 3C11 | Mouse | WB, DB, ICC/IF, ELISA | Hu, Ms, Rt |
| SMC-531 | Alpha Synuclein | 10H7 | Mouse | WB, DB, ICC/IF, ELISA | Hu, Ms, Rt |
| SMC-532 | Alpha Synuclein | 3F8 | Mouse | WB, DB, ICC/IF, IHC, ELISA | Hu, Ms, Rt |
| SMC-533 | Alpha Synuclein | 4F1 | Mouse | WB, DB, ICC/IF, IHC, ELISA | Hu, Ms, Rt |
| SMC-600 | Alpha Synuclein | J18 | Rabbit | WB, ICC/IF, IHC, ELISA | Hu, Ms |
| SPC-742 | Alpha Synuclein (pSer129) | PAb | Rabbit | WB, ELISA | Hu, Ms, Rt |
| SPC-800 | Alpha Synuclein | PAb | Rabbit | WB, ICC/IF, IHC, ELISA | Hu, Ms, Rt |
| SPC-1435 | Alpha Synuclein (pTyr136) | PAb | Rabbit | WB | Hu, Ms, Rt |
| SMC-617 | Anti-Alpha Synuclein Antibody (Aggregate-Specific) [2F11] | 2F11 | Mouse | WB, DB, IP, IHC, ICC-IF ImmunoGold | Hu, Ms |
TEM of kinetically stable alpha synuclein oligomers (SPR-484). These oligomers are generated without the addition of any inducers or inhibitors.
The picture below shows Parkinson’s-associated pSer129 pathology induced in rat primary dopaminergic cells with SPR-484.
-in-SK-N-BE-cells.png)
Alpha Synuclein Antibody (SMC-531) in SK-N-BE cells
Alpha Synuclein Antibody (SMC-800) in human cerebellum